Aktiengesellschaft Bayer, 10% Owner at CRISPR Therapeutics AG (CRSP), bought 527,472 shares at $22.75 ($12.0M) on 2018-01-05, disclosed to the SEC on 2018-01-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.